Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Esophageal Neoplasm Metastatic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04797507
What this trial is testing

SHR-1210 in Combination With Anlotinib in Patients With Advanced or Metastatic Esophageal Squamous Cell Cancer

Who this might be right for
SHR-1210AnlotinibAdvanced Esophageal Squamous Cell Cancer
Peking Union Medical College Hospital 33
Testing effectiveness (Phase 2)WithdrawnNCT00824811
What this trial is testing

Topical Cyclosporine vs. Placebo for Epiphora Associated With Docetaxel

Who this might be right for
Epiphora
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT03528876
What this trial is testing

FOLFIRI Alternate With FOLFOX in Untreated Metastatic Gastric and Esophageal Adenocarcinoma

Who this might be right for
Metastatic Gastro-esophageal Adenocarcinoma
University of Saskatchewan 36
Not applicableStudy completedNCT05303740
What this trial is testing

Anlotinib Retrospective Study for Esophageal Cancer

Who this might be right for
Esophageal Neoplasms
Feng Wang 300
Early research (Phase 1)Looking for participantsNCT06500052
What this trial is testing

BL-M17D1 in Patients With Locally Advanced or Metastatic HER2 Positive/Lower Expression Gastrointestinal Cancer and Other Solid Tumors

Who this might be right for
Esophageal CancerGastric CancerPancreatic Cancer+2 more
Sichuan Baili Pharmaceutical Co., Ltd. 20
Early research (Phase 1)Study completedNCT00003548
What this trial is testing

Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal Cavity

Who this might be right for
Cancer
NYU Langone Health 20
Early research (Phase 1)Study completedNCT00252889
What this trial is testing

Doxil Topotecan Doublet Cancer Study

Who this might be right for
Small Cell Lung CancerPancreatic CancerHead and Neck Cancer+2 more
Christiana Care Health Services 20
Large-scale testing (Phase 3)UnknownNCT02677597
What this trial is testing

Cisplatin Combined With S-1 or Paclitaxel as First-line Treatment for Metastatic Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Fudan University 268
Early research (Phase 1)Study completedNCT00635596
What this trial is testing

Phase I Study of MT110 in Lung Cancer (Adenocarcinoma and Small Cell), Gastric Cancer or Adenocarcinoma of the Gastro-Esophageal Junction, Colorectal Cancer, Breast Cancer, Hormone-Refractory Prostate Cancer, and Ovarian Cancer

Who this might be right for
Solid Tumors
Amgen Research (Munich) GmbH 65
Testing effectiveness (Phase 2)Looking for participantsNCT06532799
What this trial is testing

TIL Therapy Combined With Pembrolizumab for Advanced or Metastatic Refractory Stomach and Esophageal Cancer

Who this might be right for
Stomach CancerStomach Cancer RecurrentStomach Cancer, Adenocarcinoma+4 more
Essen Biotech 75
Testing effectiveness (Phase 2)Study completedNCT00411151
What this trial is testing

Efficacy and Safety of Sunitinib in Metastatic Gastric Cancer

Who this might be right for
Gastric AdenocarcinomaBarrett Esophagus
Johannes Gutenberg University Mainz 52
Testing effectiveness (Phase 2)Study completedNCT00006245
What this trial is testing

Flavopiridol and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer That Has Not Responded to Previous Paclitaxel

Who this might be right for
Esophageal Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT06128551
What this trial is testing

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Who this might be right for
Non-Small Cell Lung Cancer (NSCLC)Colorectal CancerPancreatic Ductal Adenocarcinoma
Revolution Medicines, Inc. 534
Large-scale testing (Phase 3)Study completedNCT03430843
What this trial is testing

Tislelizumab (BGB-A317) Versus Chemotherapy as Second Line Treatment in Participants With Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
BeiGene 512
Post-approval studies (Phase 4)UnknownNCT00274885
What this trial is testing

Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer

Who this might be right for
Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group 58
Testing effectiveness (Phase 2)Ended earlyNCT05070247
What this trial is testing

TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Pancreatic CancerHepatocellular CancerMesothelioma+7 more
Takeda 61
Early research (Phase 1)Not Yet RecruitingNCT07154108
What this trial is testing

Endostatin Adenovirus With Checkpoint Inhibitor in Advanced Head and Neck or Esophageal Cancer

Who this might be right for
Esophageal CancerHead and Neck Cancer (H&Amp;Amp;Amp;N)
Sichuan University 40
Testing effectiveness (Phase 2)Study completedNCT01715233
What this trial is testing

Phase II Study Using CHFR Methylation Status in Patients With Metastatic Esophageal, Gastroesophageal, Gastric Cancer.

Who this might be right for
Metastatic Esophageal CancerGastroesophageal CancerGastric Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 27
Testing effectiveness (Phase 2)Looking for participantsNCT07594626
What this trial is testing

BMS-986504 in Combination With Pemetrexed for the Treatment of Metastatic Solid Tumors With MTAP Deletion

Who this might be right for
Metastatic Biliary Tract CarcinomaMetastatic Colon CarcinomaMetastatic Esophageal Carcinoma+5 more
Northwestern University 72
Testing effectiveness (Phase 2)Looking for participantsNCT05705492
What this trial is testing

Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer

Who this might be right for
Advanced Malignant Solid NeoplasmAdvanced Biliary Tract CarcinomaAdvanced Esophageal Carcinoma+7 more
OHSU Knight Cancer Institute 66
Next Page